Platelet-Rich Plasma Injection After Anterior Cruciate Ligament Reconstruction
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Intra-Articular Platelet-Rich Plasma Injection After Anterior Cruciate Ligament Reconstruction: A Randomized Clinical Trial.
JAMA Netw Open . 2024 May 1;7(5):e2410134. doi: 10.1001/jamanetworkopen.2024.10134.One hundred twenty patients with anterior cruciate ligament (ACL) injuries were randomized to receive either postoperative intra-articular PRP injection (n=60) or no injection (control group; n=60) following ACL reconstruction. The primary outcome was the mean Knee Injury and Osteoarthritis Outcome Score (KOOS4) at 12 months postoperatively. Secondary outcomes included patient-reported outcomes, graft maturity (via MRI), and physical examinations conducted at 3, 6, and 12 months. Overall, the results indicated no statistically significant improvement in knee function or symptoms in the PRP group at 12 months. At 6 months, the PRP group showed a temporary improvement in the KOOS sports and recreation score and graft maturity.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics